| Literature DB >> 33493637 |
Prem Rajak1, Abhratanu Ganguly2, Saurabh Sarkar3, Moutushi Mandi4, Moumita Dutta5, Sayanti Podder6, Salma Khatun7, Sumedha Roy8.
Abstract
Consistent gathering of immunotoxic substances on earth is a serious global issue affecting people under pathogenic stress. Organophosphates are among such hazardous compounds that are ubiquitous in nature. They fuel oxidative stress to impair antiviral immune response in living entities. Aside, organophosphates promote cytokine burst and pyroptosis in broncho-alveolar chambers leading to severe respiratory ailments. At present, we witness COVID-19 outbreak caused by SARS-CoV-2. Infection triggers cytokine storm coupled with inflammatory manifestations and pulmonary disorders in patients. Since organophosphate-exposure promotes necroinflammation and respiratory troubles hence during current pandemic situation, additional exposure to such chemicals can exacerbate inflammatory outcome and pulmonary maladies in patients, or pre-exposure to organophosphates might turn-out to be a risk factor for compromised immunity. Fortunately, antioxidants alleviate organophosphate-induced immunosuppression and hence under co-exposure circumstances, dietary intake of antioxidants would be beneficial to boost immunity against SARS-CoV-2 infection.Entities:
Keywords: Antioxidants; COVID-19; Organophosphate; Oxidative stress; SARS-CoV-2
Mesh:
Substances:
Year: 2021 PMID: 33493637 PMCID: PMC7825955 DOI: 10.1016/j.fct.2021.112007
Source DB: PubMed Journal: Food Chem Toxicol ISSN: 0278-6915 Impact factor: 6.023
Fig. 1Putative immunotoxic mechanism of SARS-CoV-2 and OPs at sub-cellular moiety.
SARS-CoV-2 invades host cell via S1/ACE-2 interaction and replicates using replication transcription complex (RCT) within the cytosolic moiety. S1 of spike protein or viral ds/sRNA binds with respective cell surface or endosomal Toll-like receptor (TLR) to fuel downstream signaling cascades involved in activation of NF-kB and synthesis of proinflammatory cytokines. Pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs) are recognized by NLRP3 to induce pyroptosis of infected cells. Several viral proteins viz. NSP1, NSP3, ORF3b, ORF6 and PL-pro target JAK/STAT and RIG-1 pathways to dwarf interferon (IFN)-mediated anti-viral immune response. M protein blocks mitochondrial antiviral signaling protein (MAVS)-dependent activation of kinases to down-regulate IFN production. NSP1 also degrades various host mRNAs, some of them may be crucial for immune reaction against SARS-CoV-2.
Being lipophilic in nature, OP crosses cell membrane and passes through phase-I detoxification machinery to generate massive reactive oxygen species (ROS). Excess ROS and subsequent oxidative stress is the major driver of immunotoxicity. ROS inhibits phosphatases to enhance production of pro-inflammatory cytokines. ROS also stabilizes hypoxia-inducible factor 1-alpha (HIF-1α) by oxidizing prolyl-hydroxylase (PHD) to transcribe vascular endothelial growth factor (VEGF) involved in airway inflammation, airway hyper-responsiveness and lymphocyte dysfunction. ROS induced lipid peroxidation, protein degradation and DNA damage simultaneously trigger necroinflammation. OP activates suppressor of cytokine signaling-3 (SOCS3) to disrupt JAK/STAT mediated anti-viral immune response. Disruption of mitochondrial boundary is promoted by apoptosis signal regulating kinase 1 (ASK-1) which remains inactive as long as it is bound to thioredoxin. ROS oxidizes thioredoxin to encourage apoptosome or inflammasome mediated cellular demise.
Fig. 2Modulation of broncho-alveolar architecture by SARS-CoV-2 and OPs in host.
Viral components fuel necroinflammation of broncho-alveolar cells. PAMPs/DAMPs stimulate macrophages and DCs to release cytokines driving inflammation at respiratory sites. Pyroptosis damages cellular lining and disrupts the epithelial barrier leading to leakage of fluid/mucus at inner faces of broncho-alveolar chambers. This reduces the volume of alveolar-lumen required for oxygen absorption. SARS-CoV-2 invasion attracts neutrophil (NT) extravasation, degranulation of cytosolic contents (HBP, elastase, cathepsins, azurocidin, collagenase, gelatinase) and NETosis to amplify respiratory troubles. Macrophages present viral antigens to naive T-cells of mucosa associated lymphoid tissues. Activated naive T-cells differentiate into CTL and TH17 to exaggerated inflammation and cytotoxicity.
OP induced ROS and subsequent oxidative stress triggers multiple apoptotic cascades to scrape lung epithelium. Shedding of damaged cells disrupts epithelial barrier. Alongside, OP insists degranulation of mast cells (MCs) to release histamine. Histamine induces goblet cells to secrete excessive mucus in alveolar cups. These events reduce the alveolar-volume interfering with O2 absorption. Additionally, OP contamination invites infiltration of neutrophil and eosinophil (ES) to exert necroinflammation. OP inhibits M2-receptor in brain leading to elevated levels of acetylcholine (ACh). ACh mediates hyper broncho-constriction and dyspnea in human. OP also ignites tissue damage in lymphoid organs, hence may depress immune response against SARS-CoV-2.
Immunotoxic impacts of organophosphates: In vitro studies.
| Organophosphate tested | Cell type | Immunotoxic Outcome | Reference (s) |
|---|---|---|---|
| Malathion, Chlorpyrifos and Diazinon | Lymphocytes | Increased reactive oxygen species (ROS) and lipid peroxidation in lymphocytes; higher DNA damage; decreased lymphocyte viability; reduced cell proliferation and apoptosis in splenocytes; reduced activity of macrophage lysosomal enzyme and increased production of IL-1β, TNFα and nitric oxide. | |
| Human monocytic leukemia cell line | Reduced cell viability and adhesion property; reduced production of anti-inflammatory cytokines (IL-10 and IL-13) and increased production of proinflammatory cytokines (TNF-α). | ||
| Methoxychlor | Murine mast cells | Increased degranulation of mast cells via induction of FcεRI-mediated signal transduction. | |
| Dimethoate and Chlorpyrifos | Human acute monocytic leukemia cell line THP-1 | Damaged dendrites of dendritic cells; up-regulation of pro- inflammatory cytokines such as IL-1β and IL-8; declined level of protein kinases responsible for cell survival and proliferation. | |
| Diethyldithiophosphate, | Human CD4+ T-lymphocytes | Reduced antigen-induced CD4+ and CD8+ T-cell proliferation; decreased CD25 expression; reduced intracellular secretion of IL-2, IL-10 and IFN-γ. | |
| Chlorpyrifos-oxon | Human blood cultures | Higher levels of pro-inflammatory IFN-γ. | |
| Dimethyl 2,2-dichlorovinyl phosphate | NK-92CI cell (an interleukin-2 independent human NK cell line) | Suppressed expression of perforin, granzyme A and granulysin. | |
| Dimethyl 2,2-dichlorovinyl phosphate | Human and murine cell lines for NK cells, cytotoxic T lymphocyte (CTL) and lymphokine-activated killer (LAK) cells | Reduced NK, LAK and CTL activities in a dose-dependent manner; significant decrease in granzyme activity. |
Immunotoxic impacts of organophosphates: In vivo studies.
| Organophosphate tested | Dose & duration of exposure | Model animal | Immunotoxic outcome | Reference |
|---|---|---|---|---|
| Fenitrothion | 20 mg/kg b.w./day; | Male rats | Increased serum levels of TNF-α and IL-2; reduced IgG and IgM antibody titer. | |
| Chlorpyrifos | 75 mg/L; | Male rats | Significant decrement in macrophage activity, serum lysozyme activity and levels of IL-2 & IL-6; | |
| Ethephon | 1995 ppm (1/10th of the oral LD50); | Mice | Impaired antibody titer and humoral immunity; declined phagocytic activity of polymorphonuclear cells. | |
| Malathion and Parathion methyl | 0.01 LD50 daily (815 ± 28 mg/kg malathion; 25.3 ± 2.6 mg/kg parathion methyl); | Albino rats | Reduced activity of neutrophils and NK cells; impaired antibody-dependent cellular cytotoxicity. | |
| Diazinon | 10 mg/kg; | Male albino rats | Reduced population of lymphocytes and monocytes; sub-optimum level of total serum immunoglobulin titer and hemagglutination; declined blood mononuclear cell proliferation, phagocytic index and blood T-cell subtypes (CD4+ and CD8+). | |
| Chlorpyrifos and Profenofos | Chlorpyrifos: 6.75 mg/kg b.w. | Male rats | Significant increase of TNF-α; reduced levels of IgG and IgM. | |
| Parathion | 0.015, 0.15 and 1.5 mg/kg/day; | Mice | Decreased production of SRBC-specific IgM antibodies; declined expression of surface antigens in IgM- and germinal center-positive B-cells. | |
| Phosphamidon | 0.174–1.74 mg/kg b.w.; | Male albino rat | Decreased serum antibody titre; significant reduction in leukocyte and macrophage migration. | |
| Monocrotophos | 0.025 mg/kg b.w.; | Sheep | Reduced production of serum globulins and γ globulins and specific | |
| Acephate | 100–500 mg/kg b.w,; | Female Wistar rats | Low CD4, CD8, B-cell and monocyte contents. | |
| Dimethoate | 7.04–28.2 mg/kg b. w.; | Male Wistar rats | Decreased IgM-plaque forming cell content and delayed-type hypersensitivity reaction. | Ȕ |
Effect of organophosphate-exposure on immune health of human.
| Compound | Mode of exposure | Duration of exposure | Immunogenic effects | Reference |
|---|---|---|---|---|
| OP pesticides | Occupational (200 agriculture spray workers) | Chronic | Altered IgE, IgA and IgM in spray workers. | |
| Triazophos and acephate | Occupational (71 workers in a unit manufacturing triazophos and acephate) | Chronic | Elevated level of serum IgM compared to control. | |
| Insecticides containing OP and Carbamate | Occupational (55 pesticide sprayers) | Chronic | Significantly reduced antioxidant defense enzymes, IgM and IgG; Up-regulated MDA and TNF levels in exposed group. | |
| Pesticides containing OP | Occupational (64 greenhouse workers) | Chronic | Increased IL-22 concentration and decreased immunocompetence in exposed workers. | |
| OP pesticides | Occupational (84 Farm workers) | 1–3 month of exposure | Increased lymphocyte count in farm workers compared with their control counterparts. | |
| OP pesticides | Occupational (20 Workers in pesticide industries) | Chronic | Increased percentage of CD8, decreased CD56, CD4/CD8 ratio and elevated level of IgG. | |
| OP agents | Environmental | Chronic exposure | Elevated T-helper 1 (Th1) and T-helper 2 (Th2) cytokines in serum; detected with asthma and wheeze problems. | |
| Byproducts of sarin (DIMP and DEMP) | Accidental | Acute exposure | Decreased NK and CTL activity. | |
| Pesticides containing OP | Occupational (304 pesticide applicators in the agricultural farms) | Chronic exposure | Reduced levels of IgM and C4; elevated levels of Neopterin and soluble tumor necrosis factor receptor (sTNF RII); compromised humoral defense system. | |
| Chlorpyrifos | Environmental | Chronic exposure | Elevated CD26 cells and a higher rate of autoimmunity in exposed groups. | |
| OP pesticides | Occupational (85 individuals working at organophosphate manufacturing unit) | Chronic exposure | Impaired neutrophil chemotaxis, higher upper respiratory tract infection |
Fig. 3Phenotypic outcome imposed by SARS-CoV-2 and OPs in human
SARS-CoV-2 infection produces multiple respiratory troubles namely pneumonitis, acute respiratory distress syndrome (ARDS) and acute bronchitis in patients. In addition subnormal immune status increases the risk for septic shock and secondary infections. Multi-organ failure (cardiac, gastrointestinal, kidney, hepatic, neurological, olfactory, gustatory, ocular & cutaneous) is evident in certain cases. OP-induced necroinflammation at broncho-alveolar sites is the mediator of pulmonary diseases like pneumonitis, emphysema, ARDS, Chronic obstructive pulmonary disease (COPD), bronchitis, asthma and rhinitis. In addition, cellular death in lymphoid tissues promotes immunosuppression. Multi-organ injuries (neural, cardiac, renal, gastrointestinal & retinal) are also reported following OP-exposure. Therefore, OP contamination can intensify health predicaments to several folds and modulate disease outcome in patients with COVID-19.
Studies reporting protective potential of antioxidants against organophosphate-induced immunotoxicity.
| Organophosphate (dose; duration) | Immunotoxic impacts | Mitigation of immunotoxicity by antioxidant(s) (dose; duration) | Reference |
|---|---|---|---|
| Malathion (20 μM & 100 μM; 24 h) | Triggered apoptosis in cultured peripheral blood mononuclear cells (PBMC) | N-acetyl cysteine (20 μM; 24 h) and curcumin (25 μM; 24 h) prevented malathion-mediated apoptosis in PBMC. | |
| Malathion (10 mg/kg; 60 days) | Decreased total immunoglobulins and circulatory immune complexes in chick | Vitamin E (150 IU/kg; 60 days) and selenium (0.1 mg/kg; 60 days) partially counteracted this effect. | |
| Fenitrothion (Lymphocytes incubated with 100 μL of 10−4M Fenitrothion; 48 h) | Reduced proliferation of cultured Splenic Lymphocytes | Walnut Polyphenol (0.5–10 μg/mL; 48 h) increased proliferation of Fenitrothion exposed splenic T lymphocytes (CD3+ T cells) and T-cell subsets (CD8+ T cells), as well as the secretion of the T-cell related cytokines interleukin (IL)-2, interferon-γ, IL-4 and granzyme B. | |
| Phosphamidon (0–20 μM; 6–24 h) | Fueled cytochrome | Co-administration of N-acetyl cysteine (20 μM; 6–24 h) and curcumin (25 μM; 6–24 h) attenuated mortality in human PBMCs. | |
| Chlorpyrifos (6.75 mg/kg; 8 weeks) and Profenofos (20 mg/kg; 8 weeks) | Reduced IgG, IgM levels and increased TNF-α level | Propolis (70 mg/kg; 8 weeks) and ginseng (200 mg/kg; 8 weeks) increased IgG and IgM; lowered TNF-α level. | |
| Chlorpyrifos (75 mg/L; 3–9 weeks) | Decreased macrophage activity, serum lysozyme activity and levels of interleukin-2 (IL-2) and IL-6 in rats | Co-administration of ZnO nanoparticles (200 mg/L; 3–9 weeks) ameliorated undesirable effects of CPF through elevation of macrophage and serum lysozyme activities, increased the levels of IL-2 and IL-6; corrected the oxidative stress markers. | |
| Chlorpyrifos (10.6 mg/kg; 17 weeks) | Attributed to neutropenia, lymphopenia, and monocytopenia in Wistar rats | Vitamin C (100 mg/kg; 17 weeks) ameliorated the subnormal count of leucocytes. | |
| Diazinon (10 mg/kg; 30 days) | Reduced relative lymphocyte and monocyte counts, immunoglobulin concentration, hemagglutination titer, delayed type hypersensitivity, blood mononuclear cell proliferation, phagocytic index and blood T-cell subtypes (CD4+ and CD8+) in rats | Co-administration of Hesperidin (25 mg/kg; 30 days) was able to normalize most of the hematological and immunological parameters. | |
| Chlorpyrifos (13.5 mg/kg/day; 1–2 weeks) | Decreased lymphocyte viability, neutrophil phagocytic index, total white blood cells count, relative lymphocyte count and IgG concentration | Pre and post-treatment with silymarin (70 mg/kg/day; 1–2 weeks) improved the lymphocyte viability, total white blood cell count and relative lymphocyte count. | |
| Chlorpyrifos (13.5 mg/kg; 28 days) | Decreased serum antibody titer, leukocyte migration inhibition (LMI) and macrophage migration inhibition (MMI) | Quercetin (3 mg/kg; 15 days) effectively alleviated chlorpyrifos-induced immunotoxicity. | |
| Diazinon (20 mg/kg; 4 weeks) | Exerted immunotoxicity as indicated by reduced IFN-γ and increased micronucleus indices of IL-10 and IL-4 in rats | Thymoquinone (2.5–10 mg/kg; 4 weeks) normalized the levels of IFN-γ, IL-10, IL-4 and prevented immunotoxicity. | |
| Ethephon (1995 ppm; 2 months) | Leucocytosis, neutrophilia, monocytosis, lymphocytopenia; reduced serum hemolyzing antibody titer, declined phagocytic activity of polymorphonuclear cells were recorded in mice. | Green tea extract (2 g of tea leaves/100 mL; 2 months) normalized lymphocyte count; improved humoral immune response and delayed type hypersensitivity reaction; partially ameliorated phagocytic activity of neutrophils. |